Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Taking a Number of Medications Regularly Could Give You a Serious Headache

11.11.2004


If you frequently take over-the-counter pills or prescription medication to make your headaches go away, you might get relief—temporarily. But the frequent use of headache medications to make the pain of a headache disappear could trigger chronic daily headache (CDH), according to recent commentary appearing in Headache Currents. Numerous studies have highlighted similar conclusions about the overuse of medication, giving further weight to the expert opinions from Drs Fred Sheftell and Marcello Bigal of the New England Center for Headache.



Headache Currents, a joint publication of the American Headache Society and Blackwell Publishing, just released this commentary on recent articles documenting the evidence that suggests that medication overuse is associated with CDH Sheftell and Bigal recommend that physicians need to address this with their patients by carefully examining their medical and medication history, and patients should seek medical help if they are taking pills multiple times a week on a regular basis.

“Physicians and patients need to be educated in the phenomenon of medication-overuse headaches (MOH),” says Dr Sheftell. Sheftell previously wrote an article on the negligence of the FDA and FTC in this matter, because they do not currently mandate that over-the-counter products address the dangers of overmedication, adverse events, or contra-indications in their labeling or advertising.


“Chronic daily headache is a debilitating and difficult problem to treat, often requiring specialty center care,” added Sheftell. According to the International Headache Society, CDH affects about 3 to 5% of the general population and 70 to 80% in specialty care settings, making it one of the most frequently encountered headache disorders seen in the specialty care setting. The burden of CDH-related disability is substantial and is associated with a significantly diminished health-related quality of life, decreased physical, social and occupational functioning, and worsened mental health.

Sharon Agsalda | alfa
Further information:
http://www.blackwellpublishing.com/hec

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>